Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease

BACKGROUND: The benefit of alpha-Ketoanalogues (KA) supplementation for chronic kidney disease (CKD) patients that followed low-protein diet (LPD) remains undetermined. METHODS: We extracted longitudinal data for all CKD patients in the Taiwan National Health Insurance from January 1, 2000 through D...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Che-Hsiung, Yang, Ya-Wen, Hung, Szu-Chun, Kuo, Ko-Lin, Wu, Kwan-Dun, Wu, Vin-Cent, Hsieh, Tsung-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419544/
https://www.ncbi.nlm.nih.gov/pubmed/28475591
http://dx.doi.org/10.1371/journal.pone.0176847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419544/
https://www.ncbi.nlm.nih.gov/pubmed/28475591
http://dx.doi.org/10.1371/journal.pone.0176847

Ejemplares similares